title: [ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies].
abstract: The ESMO/ECC congress (European Society for Medical Oncology/European Cancer Congress) took place in Vienna, Austria, September 25-29. The main topic of the conference was immunotherapies especially in advanced kidney cancer with nivolumab in phase III and in metastatic lung cancer with atezolizumab in phase II. Targeted therapies were also highlighted with cabozantinib proposed in advanced renal cancer or everolimus in differenciated neuroendocrine tumors grade 1 or 2. Furthermore the current challenges remain unchanged: improving patients' care through better selection and finding biomarkers using simple samples (blood or urine). Also early phases and personalized medicine found their place in the different presentations and were highlighted largely bringing new approaches in the treatment of metastatic patients.
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Bonnet
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Beinse
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Luc
authors.initials: L
authors.lastname: Cabel
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Delphine
authors.initials: D
authors.lastname: Cochereau
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Pernelle
authors.initials: P
authors.lastname: Lavaud
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Rochefort
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Emeline
authors.initials: E
authors.lastname: Tabouret
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Anthony
authors.initials: A
authors.lastname: Turpin
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Loic
authors.initials: L
authors.lastname: Verlingue
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Vicier
authors.affiliation: AERIO, 149, avenue du Maine, 75014 Paris, France; DITEP, Gustave-Roussy, 94805 Villejuif, France. Electronic address: christophe.massard@gustaveroussy.fr.
authors.forename: Christophe
authors.initials: C
authors.lastname: Massard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001317:Austria; D005060:Europe; D006801:Humans; D007167:Immunotherapy; D008495:Medical Oncology; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents
keywords: Early phase studies; Essai de phases précoces; Immunotherapies; Immunothérapies; Médecine personnalisée; Personalized medicine; Targeted therapies; Thérapies ciblées